GL1X · GenesisL1 explorer

MolNFT v1 · #116712 · protein

First domain of human bromodomain BRD4 in complex with inhibitor 4- [(1-methyl-2-oxo-1,2-dihydroquinolin-4-YL)OXY]-N-({1-[(3-methylphe METHYL]PIPERIDIN-4-YL}METHYL)BUTANAMIDE

5DLZ · Bromodomain-containing protein 4: “First domain of human bromodomain BRD4 in complex with inhibitor 4…”. X-ray diffraction, 1 ligand (5D1), 1 pocket (best druggability 0.57). MolNFT v1 #116712 on GenesisL1: 3D structure, binding…

PDB
5DLZ
Type
protein
Length
127 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bromodomain-containing protein 4
UniProt
O60885
Ligands
5D1
Pockets
1 · best druggability 0.57

Structure

x-ray diffraction · 1 distinct chain · 53% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABromodomain-containing protein 4protein12753% helix, 0% strandO60885

Ligands and binding sites

  • 5D1 · N-{[1-(3-methylbenzyl)piperidin-4-yl]methyl}-4-[(1-methyl-2-oxo-1,2-dihydroquinolin-4-yl)oxy]butanamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11130.570.84245D1

Compared structures

  • 5DLZ · FIRST DOMAIN OF HUMAN BROMODOMAIN BRD4 IN COMPLEX WITH INHIBITOR… · the same entry in another collection · chain A against A, TM-score 1.00
  • O60885 · AlphaFold monomer V2.0 prediction for bromodomain-containing protein 4 (O60885) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.